← signals
2026-07-15·AMAT·pricing change
lowup

On July 14, 2026, shares of Applied Materials (AMAT), KLA Corporation, and Teradyne skyrocketed, as reported by Yahoo...

On July 14, 2026, shares of Applied Materials (AMAT), KLA Corporation, and Teradyne skyrocketed, as reported by Yahoo Finance (source 50) and FinancialContent (source 69).

window 10devidence 95confidence score 100price AMAT $595.70

confidence score

Strong evidence: 85 independent source classes support this read.

100
low confidence85 independent source classesofficialothermarketpasses publish gate
priced-in check

AMAT has already moved up +51% over the recent 30-90 day window.

partly priced
as of 2026-07-147d n/a45d n/a90d +51%yahoo

signal brief

On July 14, 2026, shares of Applied Materials (AMAT), KLA Corporation, and Teradyne skyrocketed, as reported by Yahoo Finance (source 50) and FinancialContent (source 69). The articles note a sharp upward move but do not cite a specific catalyst such as earnings or major order announcements. Concurrently, a Morgan Stanley analyst maintained an 'Equal Weight' rating on AMAT (source 79), suggesting no fundamental upgrade. The surge may reflect broader semiconductor sector momentum or short-term trading activity. While AMAT's recent SEC filing shows solid fundamentals with $14.27B in revenue and $3.32B net income for the quarter ending May 2026 (source 1), these figures are historical and would have been previously disclosed. No new operational changes were found in the IR snapshot (source 2). The price action is noteworthy but lacks corroborating fundamental news, warranting low confidence.

What the sources said:

  • Yahoo Finance (source 50): 'Applied Materials, KLA Corporation, and Teradyne Shares Skyrocket, What You Need To Know.'
  • FinancialContent (source 69): Similar headline reporting the surge.
  • Insider Monkey (source 79): 'Morgan Stanley Maintains an Equal Weight Rating on Applied Materials, Inc. (AMAT).'

source data used

spillover entities

LRCXNVDA

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.